Microbot Medical MBOT Stock options excluded as their inclusion would be anti-dilutive (in shares)
Stock options excluded as their inclusion would be anti-dilutive (in shares) at other companies
Other financials
Where this comes from
Reported directly by Microbot Medical in its filing.
Tagged under the XBRL concept us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.
The official record: Microbot Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Microbot Medical's stock options excluded as their inclusion would be anti-dilutive (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Microbot Medical's stock options excluded as their inclusion would be anti-dilutive (in shares)?
- Microbot Medical (MBOT) reported stock options excluded as their inclusion would be anti-dilutive (in shares) of 19.4M in Q4 2025.
- How has Microbot Medical's stock options excluded as their inclusion would be anti-dilutive (in shares) changed year-over-year?
- Microbot Medical's stock options excluded as their inclusion would be anti-dilutive (in shares) increased by 152.5% year-over-year, from 7.7M to 19.4M.
- What does stock options excluded as their inclusion would be anti-dilutive (in shares) mean?
- The number of potential common shares from stock options, warrants, or convertible securities that are excluded from the diluted earnings per share calculation because their inclusion would increase earnings per share or decrease the loss per share. This metric identifies instruments that are currently 'out-of-the-money' or otherwise not dilutive to existing shareholders. It provides insight into the potential future dilution overhang that could impact equity holders.